The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcγRIIIA and augments anti-HPV immunity after nasal immunization (Q39168847)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 April 2013

Language	Label	Description	Also known as
English	The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcγRIIIA and augments anti-HPV immunity after nasal immunization	scientific article published on 10 April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

The immune complex CTA1-DD/IgG adjuvant specifically targets connective tissue mast cells through FcγRIIIA and augments anti-HPV immunity after nasal immunization (English)

1 reference

Europe PubMed Central

9 September 2017

0 references

connective tissue

1 reference

based on heuristic

inferred from title

object named as

Z Xiang

6

0 references

5

object named as

N Lycke

1 reference

Europe PubMed Central

9 September 2017

author name string

Y Fang

1

1 reference

Europe PubMed Central

9 September 2017

T Zhang

2

1 reference

Europe PubMed Central

9 September 2017

L Lidell

3

1 reference

Europe PubMed Central

9 September 2017

X Xu

4

1 reference

Europe PubMed Central

9 September 2017

publication date

10 April 2013

1 reference

Europe PubMed Central

9 September 2017

Mucosal Immunology

1 reference

Europe PubMed Central

9 September 2017

6

1 reference

Europe PubMed Central

9 September 2017

6

1 reference

Europe PubMed Central

9 September 2017

1168-1178

1 reference

Europe PubMed Central

9 September 2017

https://scigraph.springernature.com/pub.10.1038/mi.2013.16

0 references

Recent progress in mucosal vaccine development: potential and limitations

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Induction of secretory immunity and memory at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

The perfect mix: recent progress in adjuvant research

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

How do adjuvants work? Important considerations for new generation adjuvants

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mechanism of action of clinically approved adjuvants

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mast cell activators: a new class of highly effective vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mucosal targeting of a BoNT/A subunit vaccine adjuvanted with a mast cell activator enhances induction of BoNT/A neutralizing antibodies in rabbits

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mast cells contribute to the mucosal adjuvant effect of CTA1-DD after IgG-complex formation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

The mast cell IgG receptors and their roles in tissue inflammation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Fc receptor beta subunit is required for full activation of mast cells through Fc receptor engagement

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Advances in mast cell biology: new understanding of heterogeneity and function

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

FcepsilonRI aggregation promotes survival of connective tissue-like mast cells but not mucosal-like mast cells.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Heterogeneity of mast cells and phenotypic change between subpopulations

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Chondroitin sulphate inhibits connective tissue mast cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vacc

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mast cell-orchestrated immunity to pathogens

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mast cells in the development of adaptive immune responses

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Immunomodulatory mast cells: negative, as well as positive, regulators of immunity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Long term increase of mucosal mast cells in the rat induced by administration of Compound 48/80

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Fcgamma receptors as regulators of immune responses

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

FcRn: the neonatal Fc receptor comes of age.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Pulmonary administration of therapeutic proteins using an immunoglobulin transport pathway

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

HPV and cervical cancer in the 2007 report.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvants.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

A human papillomavirus type 16 vaccine by oral delivery of L1 protein.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Effect of the menstrual cycle on immunological parameters in the human female reproductive tract

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Progesterone increases susceptibility and decreases immune responses to genital herpes infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Readministration of IgE is required for repeated passive cutaneous anaphylaxis in mice.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

21 January 2018

Mast cells and macrophages in normal C57/BL/6 mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

7 January 2021

based on heuristic

inferred from DOI database lookup

Mast Cells Have a Pivotal Role in TNF-Independent Lymph Node Hypertrophy and the Mobilization of Langerhans Cells in Response to Bacterial Peptidoglycan

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

7 January 2021

based on heuristic

inferred from DOI database lookup

Mast cell-associated TNF promotes dendritic cell migration

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

7 January 2021

based on heuristic

inferred from DOI database lookup

Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of compound 48/80 and of electrical field stimulation on mast cells in the isolated mouse stomach

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

7 January 2021

based on heuristic

inferred from DOI database lookup

Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

7 January 2021

based on heuristic

inferred from DOI database lookup

IgE receptor-mediated release of nerve growth factor by mast cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2013.16

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MI.2013.16

1 reference

Europe PubMed Central

9 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39168847&oldid=1811588973"